Next Notes Nikkei JPX Inverse Index Mutual Fund (2037)

Overview

Telesis Bio, Inc., is a pioneering entity in the realm of synthetic biology, specializing in the development and distribution of advanced synthetic biology instruments, reagents, and various products and services. Catering primarily to the pharmaceutical and academic research sectors on a global scale, Telesis Bio stands at the forefront of facilitating groundbreaking research and development. Initially founded under the name Codex DNA, Inc., the company underwent a rebranding process in November 2022 to become Telesis Bio, Inc., a name that reflects its broadened vision and commitment to innovation in synthetic biology. Since its inception in 2011, Telesis Bio has established its headquarters in San Diego, California, evolving into a vital resource for government institutions, contract research organizations, and other synthetic biology companies.

Products and Services

BioXp 3250 system and BioXp 9600 system: These cornerstone systems enable researchers to efficiently transition from a digital DNA sequence to fully synthesized DNA and mRNA. By incorporating onboard next generation sequencing (NGS) library preparation, these systems streamline the synthesis process, significantly enhancing research productivity in the creation of vaccines, diagnostics, and therapeutics.

BioXp Portal: An innovative online platform that provides researchers with an intuitive guided workflow and design tools. The portal simplifies the complex process of DNA sequence creation, vector assembly, and mRNA construct design, making it more accessible to researchers and facilitating advanced synthetic biology experiments.

BioXp De Novo Kits: These kits supply essential building blocks and reagents, including the proprietary Gibson assembly branded reagents, tailored for specific synthetic biology applications. The kits are designed to support various workflow applications, enabling efficient and accurate DNA and RNA synthesis.

BioXp Select Kits: Designed to accommodate the use of DNA from sources outside of Telesis Bio, these kits enable researchers to leverage the BioXp system for a variety of synthetic biology workflows, such as cloning, mRNA generation from plasmid DNA, and cell-free amplification processes.

BioXp Next Generation Sequencing Kits: Containing all necessary reagents, these kits facilitate the seamless transition from extracted DNA or RNA to a sequencer-ready library, thereby supporting the comprehensive analysis and validation of synthetic biology constructs.

Benchtop Reagents: This category encompasses reagents required for conducting specific synthetic biology workflows directly on the benchtop, utilizing products synthesized by the BioXp system. These reagents provide flexibility for researchers to perform targeted experiments outside of the BioXp systems.

Custom Gibson Short Oligo Ligation Assembly Enzymatic DNA Synthesis Solutions: Tailored for the construction of synthetic DNA, RNA, and proteins, these solutions empower the development of next-generation biomedical advancements, including mRNA-based vaccines, diagnostics, therapeutics, and personalized medicine, addressing the growing demand for rapid and precise synthetic biology applications.